#CreatineForHealth GLP-1 receptor agonists (like semaglutide and tirzepatide) are revolutionizing obesity and type 2 diabetes care, but up to 40% of weight loss may come from lean mass
When she was switched to semaglutide, a weekly GLP-1 agonist, the symptoms persisted for two additional months
Contact your GP urgently if you experience severe or persistent abdominal pain, repeated vomiting, signs of gastrointestinal bleeding (vomiting blood or black stools), symptoms of dehydration, or unexplained weight loss beyond the expected therapeutic effect
Synthetic human growth hormone (somatropin) introduces exogenous growth hormone directly into the body
Do you regain weight after stopping semaglutide or tirzepatide
If further improvement is needed after another 4 weeks, the dose can be raised to 2 mg weekly